Results by group13

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 13 of 13

Outcome	Group	Value	Spread	Units
Complete Remission Rate After Primary Chemotherapy	Arm A / MTX + AraC	23	95% Confidence Interval 14 to 31	Percentage of participants
Complete Remission Rate After Primary Chemotherapy	Arm B / MTX + Ara-C + Rituximab	30	95% Confidence Interval 21 to 42	Percentage of participants
Complete Remission Rate After Primary Chemotherapy	Arm C / MTX + Ara-C + Rituximab+Thiotepa	49	95% Confidence Interval 38 to 60	Percentage of participants
2 Years Failure Free Survival (FFS) After Second Randomization	Arm D / WBRT 36 Gy +/- Boost 9 Gy	76	95% Confidence Interval 65 to 87	Percentage of participants
2 Years Failure Free Survival (FFS) After Second Randomization	Arm E / BCNU + Thiotepa + APBSCT	75	95% Confidence Interval 64 to 86	Percentage of participants
2 Years Failure Free Survival (FFS)	Arm A / MTX + AraC	36	99% Confidence Interval 31 to 41	percentage of participants
2 Years Failure Free Survival (FFS)	Arm B / MTX + Ara-C + Rituximab	46	99% Confidence Interval 40 to 52	percentage of participants
2 Years Failure Free Survival (FFS)	Arm C / MTX + Ara-C + Rituximab+Thiotepa	61	99% Confidence Interval 55 to 67	percentage of participants
2 Year Overall Survival (OS)	Arm A / MTX + AraC	42	95% Confidence Interval 36 to 48	percentage of participants
2 Year Overall Survival (OS)	Arm B / MTX + Ara-C + Rituximab	56	95% Confidence Interval 50 to 62	percentage of participants
2 Year Overall Survival (OS)	Arm C / MTX + Ara-C + Rituximab+Thiotepa	69	95% Confidence Interval 64 to 74	percentage of participants
2 Year Overall Survival (OS)	Arm D / WBRT 36 Gy +/- Boost 9 Gy	76	95% Confidence Interval 65 to 87	percentage of participants
2 Year Overall Survival (OS)	Arm E / BCNU + Thiotepa + APBSCT	75	95% Confidence Interval 64 to 86	percentage of participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01011920/results

API reference For AI assistants